Q1 2025 Integra Lifesciences Holdings Corp Earnings Call Transcript
Key Points
- Integra Lifesciences Holdings Corp (IART) reported first-quarter revenue of $383 million, near the top end of their guidance range.
- The company saw solid double-digit growth across many product lines not impacted by supply availability, indicating strong underlying demand.
- Adjusted EPS for the quarter was $0.41, within the guidance range.
- The company is making targeted investments in manufacturing infrastructure to position for long-term sustainable growth.
- Integra Lifesciences Holdings Corp (IART) has established a transformation and program management office to improve execution and prioritization of key initiatives.
- Organic revenue declined by 3.5% due to the expected impact of ship holds.
- The company identified additional ship holds, increasing the expected total for the year to between $55 million and $70 million.
- Gross margins were down 220 basis points compared to the previous year, impacted by manufacturing variances and supply challenges.
- Operating cash flow for the first quarter was negative $11.3 million.
- The company faces a $22 million impact from tariffs in 2025, with ongoing uncertainty around global trade negotiations.
Good day, and thank you for standing by. Welcome to the Integra LifeSciences first-quarter 2025 financial results call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your host today, Chris Ward. Senior Director of Investor Relations. Please go ahead.
Good morning, and thank you for joining the Integra LifeSciences first-quarter 2025 earnings conference call. With me on the call are Mojdeh Poul, President and Chief Executive Officer; and Lea Knight, Chief Financial Officer. Earlier this morning, we issued a press release first quarter 2025 financial results. The release and corresponding earnings presentation, which we will reference during the call, are available at integralife.com under Investors, Events and Presentations in the file named First Quarter 2025 Earnings Call Presentation.
Before we begin, I want to remind you that many of the statements made during this call may be considered forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
